Colitis: Aetiologies And Therapeutic Strategies

by
Edition: 1st
Format: Hardcover
Pub. Date: 2006-04-01
Publisher(s): SPRINGER
List Price: $269.00

Rent Textbook

Select for Price
There was a problem. Please try again later.

New Textbook

We're Sorry
Sold Out

Used Textbook

We're Sorry
Sold Out

eTextbook

We're Sorry
Not Available

How Marketplace Works:

  • This item is offered by an independent seller and not shipped from our warehouse
  • Item details like edition and cover design may differ from our description; see seller's comments before ordering.
  • Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
  • Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
  • Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.

Summary

Ulcerative colitis and Crohn's disease remain a major challenge within gastroenterology. Their aetiology remains unknown and provides a major intellectual challenge, although much progress is being made in understanding the influence of gene mutation on susceptibility to disease and on the course and behaviour of that disease. Diagnostic methods have improved and the advent of colonoscopy, with the ability to take multiple biopsy specimens, has not only widened our diagnostic vision but has allowed the detection of dysplasia. Surveillance colonoscopy has been introduced as a result and continues to stir up controversy. Treatment, having remained static for almost 50 years, has become enormously exciting, with many new avenues being explored. It has been informed by progress in our understanding of disease pathogenesis and, as such, is highly stimulating and provides an excellent paradigm for treating disorders of unknown aetiology. The book, the proceedings of Falk Symposium 147 on 'Colitis: Diagnosis and Therapeutic Strategies', held in Birmingham, UK, May 6'7, 2005, provides an update for any gastroenterologist, medical or surgical, with an interest in inflammatory bowel disease. Clinically important aspects of diagnosis and treatment are covered but underpinned by scientific mechanisms. It is an exciting book which looks into the future as well as informing current practice.

Table of Contents

List of principal contributors
ix
List of chairpersons
xiii
Preface xv
SECTION I: DIAGNOSIS
K Geboes
D Sachar
Role of capsule encoscopy in Crohn's disease
3(4)
S Bar-Meir
Endoscopy in Crohn's disease
7(7)
GNJ Tytgat
Colitis diagnosis and therapeutic strategies -- how, what and when to biopsy
14(11)
BF Warren
SECTION II: MICROSCOPIC COLITIS
T Tysk
BF Warren
Epidemiology of microscopic colitis
25(8)
F Fernandez-Banares
Microscopic colitis: histological classification
33(12)
K Geboes
G de Hertogh
P Van Eyken
KP Geboes
Mechanisms of pathogenesis in microscopic colitis
45(7)
J Bohr
Microscopic colitis: treatment
52(11)
A Tromm
SECTION III: PREDICTING OUTCOMES
MA Kamm
M Keighley
Predicting the natural history of inflammatory bowel disease
63(7)
S Vermeire
Can we predict who develops extraintestinal manifestations?
70(7)
T Orchard
Colitis: predicting outcomes -- who gets cancer?
77(10)
A Forbes
SECTION IV: CORTICOSTEROID THERAPY
JF Colombel
A Forbes
Mechanisms of steroid action and resistance in inflammatory bowel disease
87(11)
D Kelleher
R McManus
Budesonide for ulcerative colitis
98(13)
AS Pena
I Marin-Jimenez
How do I use steroids in Crohn's disease?
111(9)
J Scholmerich
Why corticosteroids should not be used as first-line therapy for Crohn's disease
120(9)
JM Rhodes
SECTION V: AZATHIOPRINE
S Ghosh
AS Pena
Azathioprine: molecular mechanism of action
129(6)
MF Neurath
Pharmacogenetics of azathioprine - useful in clinical practice?
135(7)
R Iacob
J-F Colombel
Azathioprine: long-term side-effects
142(10)
EV Loftus Jr
State-of-the-Art Lecture: Trials and complications of ileal pouch surgery
152(31)
SP Bach
NJMcC Mortensen
SECTION VI: IMMUNOMODULATORY THERAPY
SPL Travis
A Tromm
Biologics in ulcerative colitis
183(10)
TJ Creed
CSJ Probert
SECTION VII: CANCER AND IBD
S Prantera
J Satsangi
Diagnosis of colitis associated dysplasia: new colonoscopic techniques
193(12)
R Kiesslich
MF Neurath
Can we prevent cancer using current drugs?
205(15)
E Hertervig
Management of low-grade dysplasia in inflammatory bowel disease
220(6)
S Itzkowitz
Low-grade dysplasia in flat mucosa: is it relevant?
226(9)
A Axon
SECTION VIII: NEW THERAPEUTIC APPROACHES
F Pallone
EF Stange
Leucocytapheresis
235(6)
J Emmrich
Helminths and immune modulation of inflammatory bowel disease
241(9)
JV Weinstock
DE Elliott
Probiotics for inflammatory bowel disease
250(11)
P Marteau
Index 261

An electronic version of this book is available through VitalSource.

This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.

By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.

Digital License

You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.

More details can be found here.

A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.

Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.

Please view the compatibility matrix prior to purchase.